<DOC>
	<DOCNO>NCT01856998</DOCNO>
	<brief_summary>The purpose study evaluate therapeutic equivalence , base pharmacodynamic parameter Propofol 2 % ( 20 mg/mL ) MCT Fresenius Diprivan® 20 mg/mL ( AstraZeneca ) , administer target control infusion ( TCI ) .</brief_summary>
	<brief_title>Therapeutic Equivalence ( TE ) Study Propofol 2 % MCT Fresenius ( MCT=Medium-Chain Triglycerides ) Compared With Diprivan® Patients Undergoing Elective Surgery</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<criteria>1 . Male female subject ≥18 year &lt; 65 year old 2 . Able understand give sign date write informed consent 3 . Body mass index ( BMI ) ≥20 ≤30 kg/m² screen 4 . ASA ( American Society Anesthesiologists ) physical status 1 2 5 . Undergoing elective , minor orthopedic , vascular , urological , gynecological surgery 6 . Patients affiliate social security scheme benefit correspond right cover 1 . The following planned procedure exclude : Day surgery Emergency surgery Total hip total knee replacement Requiring open great cavity body ( cranium , thorax , peritoneum , pelvis ) With routine risk , even low , hemorrhage severe enough require administration colloid blood product With routine risk , even low , death soon procedure Vascular surgery involve aorta , vena cavae , iliac artery , femoral artery 2 . Intended administration IV medication central venous catheter ( Note : central venous catheter may use obtain Pharmacokinetic ( PK ) sample , though port catheter use administration product , include crystalloid infusion `` keep line open '' rate ) 3 . Administration general anesthesia propofol within 7 day prior randomization 4 . History hypersensitivity propofol , egg , soya , peanut , constituent study drug 5 . ASA physical status ≥3 6 . History major anesthesia complication include , limited : Clinically significant hypoxia Profound hypotension Anaphylaxis anaphylactic reaction Unpredictable anesthesia agent requirement 7 . History difficult airway management include , limited : Problematic artificial ventilation face mask Repeated difficulty placement laryngeal mask airway ( LMA ) Difficult laryngeal intubation ( CormackLehane grade 3 4 ) require alternative technique e.g . fibreoptic awake laryngeal intubation 8 . History difficult venous access 9 . Myocardial infarction within 6 month randomization cardiac reperfusion procedure within 6 week randomization 10 . Significant respiratory , cardiovascular , liver renal disease assess investigator 11 . Active systemic infection ( localized infection relate surgical procedure allowable long indication systemic involvement ) 12 . History psychiatric disorder , include use sedatives antidepressant reason , within 6 month prior randomization 13 . Alcohol substance abuse within 2 year prior randomization , well duration study 14 . Use medication could reduce subject 's respiratory and/or cardiac output 15 . Female subject pregnant , breastfeeding , lactate 16 . Hemoglobin &lt; 7.5 g/dL screen randomization 17 . Platelets &lt; 50,000 x 10³/μL screen randomization 18 . ECG finding detect screen consistent subject 's medical history warrant cardiology review 19 . Participation interventional clinical study within 6 month screen 20 . History Propofol infusion syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Therapeutic Equivalence</keyword>
	<keyword>Propofol</keyword>
</DOC>